We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
+5.39%
1 Year Est. Return
+46.46%
3 Year Est. Return
+109.4%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$16.1B
AUM Growth
+$1.98B
Cap. Flow
+$1.34B
Cap. Flow %
8.3%
Top 10 Hldgs %
18.52%
Holding
1,899
New
351
Increased
456
Reduced
282
Closed
805

Top Buys

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$260M
2
BABA icon
Alibaba
BABA
+$229M
3
GILD icon
Gilead Sciences
GILD
+$168M
4
BA icon
Boeing
BA
+$151M
5
ABT icon
Abbott
ABT
+$148M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$306M
2
UNH icon
UnitedHealth
UNH
+$244M
3
VMC icon
Vulcan Materials
VMC
+$146M
4
PEP icon
PepsiCo
PEP
+$98.4M
5
ELV icon
Elevance Health
ELV
+$96.5M

Sector Composition

Rank Sector Weight
1 Healthcare 27.6%
2 Technology 15.66%
3 Consumer Discretionary 13.93%
4 Industrials 11.16%
5 Communication Services 8.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CETV
1826
DELISTED
Central European Media Enterprises Ltd
CETV
– –
-1,669
Closed -$7K
AKCA
1827
DELISTED
Akcea Therapeutics Inc
AKCA
– –
-3,736
Closed -$106K
AMTD
1828
DELISTED
TD Ameritrade Holding Corp
AMTD
– –
-81,533
Closed -$4.08M
MNTA
1829
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
– –
-8,947
Closed -$130K
PRNB
1830
DELISTED
Principia Biopharma Inc. Common Stock
PRNB
– –
-17,717
Closed -$603K
NE
1831
DELISTED
Noble Corporation
NE
– –
-200
Closed -$1K
BGG
1832
DELISTED
Briggs & Stratton Corp.
BGG
– –
-500
Closed -$6K
SDRL
1833
DELISTED
Seadrill Limited Common Stock
SDRL
– –
-300
Closed -$2K
PYX
1834
DELISTED
Pyxus International, Inc.
PYX
– –
-13,227
Closed -$316K
FG
1835
DELISTED
FGL Holdings Ordinary Shares
FG
– –
-604,805
Closed -$4.76M
I
1836
DELISTED
INTELSAT S. A.
I
– –
-81,000
Closed -$1.27M
JCP
1837
DELISTED
J.C. Penney Company, Inc.
JCP
– –
-27,404
Closed -$41K
ARCH
1838
DELISTED
Arch Resources, Inc.
ARCH
– –
-6,447
Closed -$588K
NTGN
1839
DELISTED
Neon Therapeutics, Inc. Common Stock
NTGN
– –
-7,549
Closed -$49K
MLNX
1840
DELISTED
Mellanox Technologies, Ltd.
MLNX
– –
-41,315
Closed -$4.89M
ZAYO
1841
DELISTED
Zayo Group Holdings, Inc.
ZAYO
– –
-115,743
Closed -$3.29M
CBPX
1842
DELISTED
CONTINENTAL BUILDING PRODUCTS, INC.
CBPX
– –
-9,608
Closed -$238K
WCG
1843
DELISTED
Wellcare Health Plans, Inc.
WCG
– –
-1,267
Closed -$342K
MDR
1844
DELISTED
McDermott International
MDR
– –
-560
Closed -$4K
TOO
1845
DELISTED
Teekay Offshore Partners L.P.
TOO
– –
-19,099
Closed -$23K
BOLD
1846
DELISTED
Audentes Therapeutics, Inc
BOLD
– –
-117,468
Closed -$4.58M
MDCO
1847
DELISTED
Medicines Co
MDCO
– –
-67,884
Closed -$1.9M
SMTA
1848
DELISTED
Spirit MTA REIT Common Shares of Beneficial Interest
SMTA
– –
-33,187
Closed -$215K
PVTL
1849
DELISTED
Pivotal Software, Inc.
PVTL
– –
-97,657
Closed -$2.04M
CRZO
1850
DELISTED
Carrizo Oil & Gas Inc
CRZO
– –
-118,269
Closed -$1.47M
72 73
74
75 76

Similar funds

TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
PAM
PFM Asset Management Harrisburg, Pennsylvania $5.36B AUM 21.04% 1-Year Est. Return
HB
Homrich & Berg Atlanta, Georgia $4.47B AUM 22.61% 1-Year Est. Return
MWA
Marshall Wace Asia Central, Hong Kong $4.23B AUM 69.9% 1-Year Est. Return
3SCA
36 South Capital Advisors London, United Kingdom $3.76B AUM
HFCIV
H&F Corporate Investors VII San Francisco, California $3.61B AUM 26.49% 1-Year Est. Return
DVC
Deer VIII & Co Larchmont, New York $3.56B AUM
NAM
NorthCoast Asset Management Greenwich, Connecticut $2.74B AUM 25.44% 1-Year Est. Return

Marshall Wace North America's Q2 2019 Portfolio in Review

As of Q2 2019, Marshall Wace North America held 1,899 positions worth $16.1B, up 14% from $14.1B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Marshall Wace North America deployed $1.34B of net new capital in Q2 2019, opening 351 new positions and adding to 456 existing holdings. Its largest new stake was Abbott: 1,884,363 shares worth $158M.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, down from 32% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Pfizer, an estimated $306M trimmed.

  • Marshall Wace North America's largest Q2 2019 buy was Abbott: 1,884,363 shares worth $158M.
  • Marshall Wace North America added most to Meta Platforms (Facebook) in Q2 2019, an estimated $260M increase.
  • Marshall Wace North America's biggest Q2 2019 reduction was Pfizer, cutting an estimated $306M.
  • Marshall Wace North America fully exited UnitedHealth in Q2 2019, selling an estimated $244M.
  • Marshall Wace North America's ten largest holdings make up 19% of its $16.1B portfolio in Q2 2019.
  • Marshall Wace North America opened 351 new positions and closed 805 in Q2 2019.
  • Marshall Wace North America's portfolio value rose 14% quarter-over-quarter to $16.1B.

Based on Marshall Wace North America's 13F filing for Q2 2019, filed 14 Aug 2019.